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Abstract
Background: The US Preventive Services Task Force has recommended daily folic acid supplementation for
women planning on becoming pregnant in an effort to prevent fetal neural tube defects. We evaluated pregnant
patients presenting to the emergency department to determine rates of folic acid supplementation.
Methods: We surveyed a convenience sample of pregnant patients who presented to the University of Utah
Emergency Department (ED) between 1 January 2008, and 30 April 2009, regarding pregnancy history and prior
medical care.
Results: One hundred thirty-five patients participated in the study. Eighty-four patients (62.2%) reported current
folic acid supplementation. Sixty-six patients identified themselves as Caucasian and 69 as non-Caucasian race.
There was a significant difference in folic acid use between Caucasian and non-Caucasian women (p = 0.035). The
majority of Caucasian women (71.2%) reported daily folic acid use versus approximately one-half of non-Caucasian
women (53.6%). Both groups were similar in accessing a primary care provider (PCP) for pregnancy care prior to
the ED visit (53% vs. 49.3%, p = 0.663), and rates of folic acid use were similar in those who had seen a PCP (85.7%
vs. 76.5%, p = 0.326). Language did not have a significant association with folic acid use.
Conclusion: A large percentage of pregnant ED patients did not report current folic use, and there was a
significant difference between Caucasian and non-Caucasian women in rates of folic acid supplementation. This
study highlights the potential role of the ED in screening patients for folic acid supplementation.
Introduction
In the United States, approximately one in every 1,000
pregnancies is affected by a neural tube defect (NTD)
[1]. Among the most common types of NTDs, spina
bifida and anencephaly are estimated to affect approxi-
mately 3,000 pregnancies each year in the US [2-7]. In
an effort to curtail these preventable birth defects, the
Food and Drug Administration (FDA) has suggested
that women of childbearing age consume a minimum of
400 μg (0.4 mg) of folic acid daily [1,2,8-10]. Despite
these recommendations, total folate consumption
remains well below the recommended levels in Hispanic
communities when compared to non-Hispanic commu-
nities [1-5,8,10]. Additional research has suggested that
non-Caucasian females of child-bearing age are signifi-
cantly less likely to take a prenatal vitamin [10].
Pregnant patients presenting to the emergency depart-
ment (ED) may represent a higher risk group that is less
likely to have received prenatal care or appropriate edu-
cation regarding folic acid supplementation [11]. Emer-
gency departments have been successful in performing
nursing screening and intervention for domestic vio-
lence prevention and alcohol abuse, and may represent
an appropriate setting for intervention regarding folic
acid supplementation in pregnancy [12,13].
We sought to evaluate the rates of folic acid use
among pregnant patients presenting to the ED. Further-
more, we intended to identify patient characteristics
related to folic acid use in an attempt to potentially
define the role of the ED in screening for folic acid use
and aiding in the prevention of neural tube defects.
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We conducted a survey study of a convenience sample
of pregnant ED patients over the 16-month period from
1 January 2008, through 30 April 2009 at the University
of Utah Medical Center ED in Salt Lake City, Utah. The
University of Utah ED is an urban, academic ED that
treats approximately 39,000 patients per year.
All pregnant patients in the ED were eligible to parti-
cipate. Patients were approached by trained research
associates and asked to complete a survey regarding
their pregnancy history and current medications. All
pregnant patients who participated in the study had pre-
sented with pregnancy-related complaints of abdominal
pain and/or vaginal bleeding. Research associates were
present in the ED 7 days per week from 8 a.m. until
midnight.
The survey consisted of questions regarding pregnancy
history, current medications, and prenatal care. Patients
were specifically asked the question, “Are you taking
prenatal vitamins?” We utilized this question as we felt
the term “prenatal vitamins” would be the term most
familiar to patients to describe a folic acid-containing
supplement.
Patients were asked to self-identify their race and pri-
mary language with free-text spaces in which the patient
recorded this information. Utilizing self-reported race,
patients were grouped according to reported race using
United State Census classifications [14]. In evaluating
rates of folic acid use, comparisons were made between
patients reporting Caucasian race and those reporting a
race that was not Caucasian (non-Caucasian). In two
cases, patients reported “multi-racial” as their self-
reported race. For statistical analysis, these patients were
classified as non-Caucasian.
Patients were asked about their medical care during
the pregnancy with the following question: “Have you
been to a health care professional (OB, family practi-
tioner, midwife) for care during this pregnancy?”
Patients were asked to report the date of the first day of
their last menstrual period, and gestational age was cal-
culated based on this. The survey was one that we
developed and that underwent internal revision and vali-
dation without an external validation processes (see
Appendix).
Chi-square testing and Fisher’s exact test were used
for categorical variables (SPSS v. 16.0). For associations,
we report p-value, odds ratios, and 95% confidence
intervals (CI). This study received approval from the
University of Utah Institutional Review Board (IRB).
Results
One hundred thirty-five pregnant women participated in
the study during the 16-month period. Of these, 23
patients (17%) presented with vaginal bleeding, 44
patients (32.6%) presented with abdominal pain, and 68
patients (50.1%) presented with both vaginal bleeding
and abdominal pain. The average age of the patients
was 25.1 years (range 16-42 years). The average number
of pregnancies per patient was 2.8 (range 1-9) with an
average of 1.1 previous live births per patient (range 0-
6). The average estimated gestational age was 73.2 days
(range 13-147 days) (see Table 1).
Of the women, 62.2% reported current use of a prena-
tal vitamin at the time of the ED visit. We noted a sig-
nificant difference in prenatal vitamin use between
patients who identified themselves as Caucasian and
those who self-identified as a non-Caucasian race. Sixty-
six patients (48.9%) identified themselves as Caucasian,
while 69 patients (51.1%) identified themselves as of
non-Caucasian race. Patients who self-reported a non-
Caucasian race identified themselves as follows: Hispanic
(68.1%), African American (11.6%), Native American
(7.2%), Pacific Islander (5.8%), Asian (4.3%), and multi-
racial (2.9%); 71.2% of Caucasian women reported pre-
natal vitamin use compared to 53.6% of non-Caucasian
women (p = 0.035, OR = 2.14, 1.05-4.36) (see Figure 1)
Caucasian and non-Caucasian patients were similar in
reporting having seeing a primary care provider for pre-
natal care prior to the ED visit (53% vs. 49.3%, p =0 . 6 6 3 ,
OR = 1.16, 0.59-2.28). Among those who were seen by a
primary care provider (n = 69), rates of prenatal vitamin
use were similar (Caucasians: 85.7% vs. non-Caucasians:
76.5%, p = 0.326, OR = 1.85, 0.54-6.35). Language did not
have a significant association with parental vitamin use.
Of the patients, 25.9% identified their primary language
as a language other than English. Sixty-six percent of
patients who stated their primary language was English
reported prenatal vitamin use vs. 51.4% who identified
their primary language as a language other than English
(p = 0.126, OR = 1.83, 0.84-4.01).
Discussion
Approximately 70% of neural tube defects could be pre-
vented with the consumption of folic acid before con-
ception and in the early stages of pregnancy [5,8-10]. As
we have reported in our study, a significant percentage
Table 1 Patient Characteristics
Characteristic Number/Percentage (Range)
Total Patients 135
Average Age 25.1 years (16-42)
Number of Pregnancies 2.8 (1-9)
Previous Live Births 1.1 (0-6)
Average Gestational Age 73.2 days (13-147)
Non-Caucasian Race 51.10%
Current Prenatal Vitamin Use 62%
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ment did not report current folic acid supplementation.
Perhaps even more notable, this difference was particu-
larly pronounced when comparing patients who self-
identified as a non-Caucasian race. Previous studies
have noted a more significant dietary deficiency of folic
acid in non-Caucasian patients [1,5,8,10].
The reason for lower rates of folic acid supplementa-
tion in non-Caucasian patients in our study does not
seem to be related to language barriers leading to mis-
understanding or failure to receive appropriate guide-
lines for folic acid supplementation. We found that
those who identified a primary language other than Eng-
lish were not significantly less likely to reports folic acid
supplementation. This difference also did not seem to
be related to discrepancies in the prenatal care provided
between Caucasian and non-Caucasian patients who saw
a physician prior to their ED visit. Of those who had
reported visiting a health care provider prior to their ED
visit, folic acid supplementation was similar between
these two groups.
Given these findings, this study suggests a potential
role for the ED in the prevention of NTDs. As this study
demonstrates, a high percentage of pregnant patients are
not currently using folic acid supplementation. Folic acid
supplementation education delivered in the ED may be a
viable public health initiative. This intervention could be
as simple as screening childbearing-age women for folic
acid use and providing an information sheet on the bene-
fits of folic acid supplementation, as well as a list of com-
munity resources available to these patients.
While our study suggests the potential for a folic acid
intervention program, it does not suggest that such an
intervention would be effective in improving the rates of
folic acid supplementation among pregnant women.
Other ED-based intervention programs, however, have
previously proven effective. Examples of these include
screening for domestic violence and alcohol abuse
[12,13]. Further research would seem indicated to deter-
mine the efficacy of an ED-based folic acid supplemen-
tation intervention.
Limitations
This study did not evaluate the outcomes of the study
participants to determine pregnancy complications for
those who did not report folic acid use. For many of the
patients we evaluated, it is likely that initiation of folic
acid at the time of their visit may have been too late to
prevent neural tube defects, given that the range of
reported gestational age extended to 147 days.
As a convenience sample of patients, this does not
represent all pregnant ED patients during the study per-
iod, and thus may not adequately represent folic acid use
in this population. The convenience sample is subject to
bias based on both the availability of research associates
as well as patient willingness to participate in the survey.
Thus, this may not adequately represent folic acid use
among the full spectrum of pregnant ED patients.
Similarly, our study focused only on those patients who
presented to the ED with pregnancy-related symptoms.
Ideally, folic acid supplementation would be initiated by
all women of childbearing age. Although we presume
that the rate of folic acid use in this larger population
would be even less than in the pregnant patients we stu-
died, we are unable to draw conclusions related to this
population from the information we have gathered.
It is unclear whether low rates of folic acid supple-
mentation may have been unique to our catchment
area, or whether these lower rates, particularly among
non-Caucasian patients, may have been due to charac-
teristics of the primary care network or health care
initiatives in our region. Similarly, while we did not find
that language was significantly associated with differ-
ences in folic acid supplementation, language barriers or
cultural differences between patient and physician may
affect the efficacy of physician counseling and recom-
mendations. We have not specifically evaluated the mul-
tiple questions related to the provider-patient dynamic
and how this may have affected the results that we
noted in our study.
Conclusion
Neural tube defects may be prevented through folic acid
supplementation in early pregnancy. Our study demon-
strated both a low rate of folic acid supplementation
among pregnant ED patients and a significantly lower
rate of folic acid use among non-Caucasian patients.
This study suggests the potential need for an ED-based
educational intervention program as a means to improve
folic acid supplementation in pregnancy.
Figure 1 Prenatal vitamin use by self-identified race.
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Emergency Department Pregnancy Study Questionnaire
Please tell us about yourself:
Name:
Telephone number:
E-mail address or alternative phone number:
Primary language:
Age:
Race:
Please tell us about your previous pregnancy
history:
How many times have you been pregnant?
How many times have you given birth?
How many times have you had live births?
How many spontaneous failed pregnancies or miscar-
riages have you experienced?
How many induced abortions have you experienced?
How many Cesarean deliveries have you experienced?
Have you ever been hospitalized for treatment of pel-
vic inflammatory disease? Yes No
Have you ever been treated as an outpatient (out of
the hospital) for a pelvic infection from chlamydia or
gonorrhea? Yes No
Have you ever used an intrauterine device (IUD) for
birth control? Yes No
Have you ever had pelvic surgery (not including cesar-
ean section)? Yes No
Please tell us about the symptoms you have experi-
enced recently:
What was the date of your last menstrual period?
Have you had an ultrasound to evaluate your preg-
nancy prior to this visit? Yes No
If so, what is your estimated delivery date based on
this ultrasound?
Have you been to a health care professional (OB,
family practitioner, midwife) for care during this preg-
nancy? Yes No
Are you taking prenatal vitamins? Yes No
Are you taking aspirin? Yes No
Do you smoke? Yes No
Please list any other medications you are currently
taking:
How much pain are you experiencing? (please circle
one of the choices below)
None (no pain)
Mild (less than your menstrual period)
Moderate (equal to your menstrual period)
Severe (more than your menstrual period)
How much vaginal bleeding are you experiencing?
(please circle one of the choices below)
None (no bleeding)
Mild (less than your menstrual period)
Moderate (equal to your menstrual period)
Thank you for your participation in this study.
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